Ciprofloxacin and epirubicin synergistically induce apoptosis in human urothelial cancer cell lines

Urologia Internationalis

Volumn 88, Issue 3, 2012, Pages 343-349

  Engeler, Daniel S ^a,b   Scandella, Elke ^a   Ludewig, Burkhard ^a   Schmid, Hans Peter ^b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

Author keywords

Ciprofloxacin; Drug synergism; Epirubicin; Intravesical administration; Urinary bladder neoplasms

Indexed keywords

CIPROFLOXACIN; EPIRUBICIN; NITROBLUE TETRAZOLIUM;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL LINE, TUMOR; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPIRUBICIN; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84860323711     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000336130     Document Type: Article

References (18)

1. Sylvester RJ, Oosterlinck W, van der Meijden AP: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004; 171: 2186-2190. (Pubitemid 38625431)
2. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L: Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004; 56: 185-229. (Pubitemid 38720829)
3. Aranha O, Wood DP Jr, Sarkar FH: Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res 2000; 6: 891-900. (Pubitemid 30159346)
4. Aranha O, Zhu L, Alhasan S, et al: Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells. J Urol 2002; 167: 1288-1294. (Pubitemid 34132072)
5. Seay TM, Peretsman SJ, Dixon PS: Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. J Urol 1996; 155: 757-762. (Pubitemid 26023598)
6. Ebisuno S, Inagaki T, Kohjimoto Y, et al: The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro. Cancer 1997; 80: 2263-2267. (Pubitemid 28007397)
7. Kamat AM, DeHaven JI, Lamm DL: Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer. Urology 1999; 54: 56-61. (Pubitemid 29323333)
8. Kamat AM, Lamm DL: Antitumor activity of common antibiotics against superficial bladder cancer. Urology 2004; 63: 457-460.
9. Turkeri LN, Akdas G, Ozyurek M, et al: The role of in vitro chemosensitivity tests to predict the clinical efficacy of antineoplastic agents in genito-urinary tumors. Arch Esp Urol 1998; 51: 398-404.
10. Rasheed S, Gardner MB, Rongey RW, et al: Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst 1977; 58: 881-890. (Pubitemid 8073554)
11. Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55.
12. Gonzalez MA, Uribe F, Moisen SD, et al: Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 1984; 26: 741-744. (Pubitemid 15211673)
13. Nishikawa T, Kohjimoto Y, Nishihata M, Ebisuno S, Hara I: Synergistic antitumor effects of fleroxacin with 5-fluorouracil in vitro and in vivo for bladder cancer cell lines. Urology 2009; 74: 1370-1376.
14. Burgues JP, Gomez L, Pontones JL, et al: A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids. Eur Urol 2007; 51: 962-969.
15. Phillips RM, Clayton MR: Plateau-phase cultures: an experimental model for identifying drugs which are bioactivated within the microenvironment of solid tumours. Br J Cancer 1997; 75: 196-201. (Pubitemid 27019562)
16. Shelley MD, Mason MD, Kynaston H: Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev 2010; 36: 195-205.
17. Lovisolo JAJ, Vio P, Benvenuti C, et al: Possible effect of intravenous perioperative pefloxacin on recurrence rate and disease-free interval in patients with superficial bladder cancer. Curr Ther Res 1996; 58: 266-271. (Pubitemid 27236728)
18. National Cancer Institute (NCI): Ciprofloxacin compared with cephalexin in treating patients with bladder cancer. Clinicaltrials. gov identifier NCT00003842. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00003824.